Participants 117 174 3
subjects diagnosed with an autism spectrum disorder (ASD)
Participants 355 385 3
subjects diagnosed with an ASD
Participants 545 687 4
trial using oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13) in children, 3-13 years of age, with a diagnosis of an ASD.
Participants 1371 1401 3
subjects diagnosed with an ASD
